{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ02568",
      "entity_text" : "Con A vs. Con A",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00166",
      "entity_text" : "MHC II",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "gene_or_gene_product"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "At 16 h post-Con A treatment, MHC II expressing IMs remained increased in the Con A treated groups and were similar in the Con A vs. Con A plus mirtazapine groups (XREF_FIG).",
  "reading_complete" : "2020-08-04T11:28:12Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T11:25:15Z",
  "trigger" : "increased",
  "evidence" : [ "MHC II expressing IMs remained increased in the Con A treated groups and were similar in the Con A vs. Con A" ],
  "pmc_id" : "6474187",
  "score" : 0
}